Overview

The Effects of Levetiracetam on Alcohol Dependent Subjects

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study will attempt to examine whether Levetiracetam (Keppra (TM)) can help people with alcohol dependence cut down on their alcohol consumption. In addition, the investigation will assess the effectiveness of Keppra on reducing withdrawal symptoms post alcohol cessation. Matched group of historical controls of alcohol dependent patients receiving placebo will be used for comparison.Based on the mechanism of action of Keppra we hypothesize that it may be effective in promoting abstinence and reducing drinking behavior in alcohol dependent patients.
Phase:
Phase 4
Details
Lead Sponsor:
Boston University
Collaborator:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam